Sign in
Taking peopleNo phase

Hypothermia Versus Normothermia After Extracorporeal Cardiopulmonary Resuscitation for Out-of-hospital Cardiac Arrest

Key facts

Who runs it
Kagawa University
Where
Japan29 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
468 people, planned
Started
6 Jan 2025
Expected to end
31 Jan 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Temperature control
Record updated
7 August 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • OHCA
  • Age of 18-75 years, known or estimated
  • An initial cardiac arrest rhythm of ventricular fibrillation/pulseless ventricular tachycardia or pulseless electrical activity

Who cannot take part

  • Do Not Attempt Resuscitation) order confirmed prior to temperature control
  • Concomitant illness, such as malignancy, shortens life expectancy (180-day survival unlikely)
  • OHCA of presumed non-cardiac etiology
  • Surgical intervention before temperature control (e.g., surgical intervention for the primary disease or complications related to resuscitation/ECMO procedures)
  • Known cerebral performance category (CPC) of 3-4 before cardiac arrest
  • Known chronic obstructive pulmonary disease with home oxygen therapy
  • ECMO initiated after sustained return of spontaneous circulation (ROSC) and patients with sustained ROSC before ECMO initiation
  • Time from emergency call or witnessed arrest to hospital arrival of >60 min
  • Time from hospital arrival to ECMO initiation of >60 min
  • Pre-hospital ECPR
  • Unavailability of the ECMO heat exchanger for temperature control
  • Glasgow Coma Scale score before temperature control of >8
  • Core body temperature upon hospital arrival of ≤32ºC
  • Limitations in intensive care before temperature control
  • Known or suspected pregnancy
  • Consent not obtained or withdrawn by the participant or surrogate
  • Other reasons, physician's decision not to enroll the patient

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The SAVE-J NEUROTHERM trial is a cluster randomized trial that evaluated and compared the mortality risk, neurological outcomes, and adverse events between patients who underwent hypothermia and those who underwent normothermia after extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest.

The 2 groups in the trial

  • NormothermiaExisting treatment, for comparison

    Temperature control at 36 °C

    Treatment: Temperature control

  • HypothermiaTreatment being tested

    Temperature control at 33-34 °C

    Treatment: Temperature control

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Hypothermia Versus Normothermia After Extracorporeal Cardiopulmonary Resuscitation for Out-of-hospital Cardiac Arrest: A Cluster Randomized Trial (SAVE-J NEUROTHERM Trial)
Criteria questions
Built from NCT06776549, who can take part
Record updated
7 August 2026